David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
1801
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.28M | ﹤0.01% |
+23,500
| New | +$3.34M |
|
|
BROGU
1802
DELISTED
Twelve Seas Investment Company Units
BROGU
| $3.27M | ﹤0.01% |
+325,000
| New | +$3.27M |
|
1803
PUT
Gartner
IT
$12.4B
| $3.27M | ﹤0.01% |
24,600
+6,500
| +36% | +$832K |
|
1804
PUT
Qualys
QLYS
$6.09B
| $3.26M | ﹤0.01% |
38,700
+33,600
| +659% | +$2.7M |
|
|
ADSW
1805
DELISTED
Advanced Disposal Services Inc
ADSW
| $3.26M | ﹤0.01% |
131,645
+108,698
| +474% | +$2.53M |
|
|
B
1806
DELISTED
Barnes Group Inc.
B
| $3.26M | ﹤0.01% |
55,345
+7,929
| +17% | +$471K |
|
|
ISBC
1807
DELISTED
Investors Bancorp, Inc.
ISBC
| $3.25M | ﹤0.01% |
+254,244
| New | +$3.43M |
|
|
ONIT
1808
Onity Group
ONIT
$294M
| $3.25M | ﹤0.01% |
54,728
+13,844
| +34% | +$908K |
|
|
IPHS
1809
DELISTED
Innophos Holdings, Inc.
IPHS
| $3.25M | ﹤0.01% |
68,278
-19,473
| -22% | -$886K |
|
1810
Digi International
DGII
$2.88B
| $3.24M | ﹤0.01% |
245,624
-22,907
| -9% | -$273K |
|
|
NE
1811
DELISTED
Noble Corporation
NE
| $3.24M | ﹤0.01% |
512,271
+489,574
| +2,157% | +$2.51M |
|
1812
NN Inc
NNBR
$292M
| $3.24M | ﹤0.01% |
171,193
+3,012
| +2% | +$64.9K |
|
|
ITCI
1813
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.23M | ﹤0.01% |
183,070
-39,501
| -18% | -$802K |
|
|
GTLS
1814
CALL
DELISTED
Chart Industries
GTLS
| $3.23M | ﹤0.01% |
+52,400
| New | +$3.29M |
|
1815
Adtran
ADTN
$653M
| $3.23M | ﹤0.01% |
217,353
-84,527
| -28% | -$1.26M |
|
|
LXFT
1816
DELISTED
Luxoft Holding, Inc.
LXFT
| $3.23M | ﹤0.01% |
87,569
+15,067
| +21% | +$581K |
|
1817
CALL
RingCentral
RNG
$5.48B
| $3.22M | ﹤0.01% |
+45,800
| New | +$3.28M |
|
1818
Rexford Industrial Realty
REXR
$8.39B
| $3.22M | ﹤0.01% |
+102,611
| New | +$3.14M |
|
1819
Kennametal
KMT
$2.23B
| $3.22M | ﹤0.01% |
89,718
+69,730
| +349% | +$2.68M |
|
1820
CALL
FMC
FMC
$1.4B
| $3.21M | ﹤0.01% |
+41,508
| New | +$3.08M |
|
1821
CALL
HCA Healthcare
HCA
$92.8B
| $3.21M | ﹤0.01% |
31,300
+19,900
| +175% | +$2.01M |
|
1822
Dine Brands
DIN
$449M
| $3.21M | ﹤0.01% |
42,901
-1,864
| -4% | -$135K |
|
|
UNVR
1823
DELISTED
Univar Solutions Inc.
UNVR
| $3.21M | ﹤0.01% |
122,210
-12,174
| -9% | -$336K |
|
1824
Quad
QUAD
$526M
| $3.2M | ﹤0.01% |
153,553
-4,724
| -3% | -$103K |
|
1825
CALL
Affiliated Managers Group
AMG
$9.45B
| $3.2M | ﹤0.01% |
21,500
+11,500
| +115% | +$1.9M |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.